2637 — Fujian Haixi Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$10.39bn
- HK$10.46bn
- CNY466.68m
Annual cashflow statement for Fujian Haixi Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 73.8 | 133 | 149 |
| Depreciation | |||
| Non-Cash Items | 18.2 | 1.52 | 0.414 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -9.47 | 8.88 | 9.55 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 85.3 | 147 | 164 |
| Capital Expenditures | -31.7 | -59.5 | -179 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -22.1 | 46.7 | -200 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -53.8 | -12.8 | -379 |
| Financing Cash Flow Items | 143 | -10.1 | -14.3 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 133 | -51.5 | -1.27 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 165 | 82.8 | -216 |